Previous close | 106.52 |
Open | 107.07 |
Bid | 0.00 x 1200 |
Ask | 0.00 x 800 |
Day's range | 105.53 - 107.44 |
52-week range | 77.56 - 116.04 |
Volume | |
Avg. volume | 2,296,967 |
Market cap | 25.783B |
Beta (5Y monthly) | 0.70 |
PE ratio (TTM) | 42.06 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.00 (1.89%) |
Ex-dividend date | 28 Mar 2024 |
1y target est | N/A |
Today, Cardinal Health (NYSE: CAH) announced that construction has begun for a new 350,000 square-foot logistics center in Columbus, Ohio, that will serve as a centralized replenishment center for the distribution of over-the-counter consumer health products in support of its core pharmaceutical business.
Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2024 on May 2, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
Cardinal Health (NYSE: CAH) today announced that the company has received approval by the Science Based Targets initiative (SBTi) for its near-term science-based greenhouse gas (GHG) emissions reduction targets. Targets are considered science-based if they align with what the latest climate science says is necessary to limit global warming to 1.5°C above pre-industrial levels.